The industry is right to welcome funding for the National One Stop Shop for clinical trials but it should be very cautious in supporting language that confuses this with actual funded access to proven treatments.
Access should not be redefined as including access via a clinical trial
May 3, 2024 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Endometriosis diagnoses in Australian GP clinics Nearly double over a decade
October 21, 2025 - -
'Patient-centric partnerships will unlock brighter and more equitable outcomes for all'
October 21, 2025 - - Latest News -
Vaccine confidence slips as Australians grow more concerned about access to healthcare
October 20, 2025 - - Latest News -
NZ's Pharmac proposes new rules to manage 'Options for Investment' list - make it shorter
October 20, 2025 - - Latest News -
Monash scientists crack genetic ‘code’ behind RNA splicing, opening door to to new therapies
October 20, 2025 - - Australian Biotech -
Radiopharm secures funding to accelerate radiopharmaceutical pipeline as data show strong momentum
October 20, 2025 - - Australian Biotech -
Neuren secures FDA 'Fast Track Designation' for NNZ-2591 in Phelan-McDermid Syndrome
October 20, 2025 - - Australian Biotech